baber/WOPTO huggingface dataset:
Patent AU-2017202542-A1 (AU)
Title: Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation
Inventor: ZHANG FENG
IPC: C12N15/63
Filed: 2017-04-19
Abstract: The invention provides for engineering and optimization of systems, methods, and compositions for manipulation of sequences and/or activities of target sequences. Provided are compositions and methods related to components of a CRISPR complex particularly comprising a Cas ortholog enzyme.
Patent AU-2017203285-A1 (AU)
Title: Foaming agent for building material/binder pastes
Inventor: VON DER SCHULENBURG GÜNZEL GRAF
IPC: C04B38/10
Filed: 2017-05-16
Abstract: Abstract A foaming agent, more particularly for the foaming of a building material/binder paste for producing pory lightweight-construction and insulating materials, is improved in terms of its stability and usefulness at relatively low outdoor temperatures. The foaming agent in the form of an aqueous-organic solution consists to an extent of at least 85 wt% of the following constituents: a) a surfactant component which comprises at least one foam-forming ionic surfactant, b) a fatty alcohol component which comprises at least one fatty alcohol and at least one ethoxylated fatty alcohol in a FA/FAEO mixing ratio of 95:5 to 0:100, c) a glycol component which comprises at least one constituent of the group of alkyl glycols, alkylene glycols up to C6 alkyl, diglycols, especially alkyl diglycols and diglycol ethers, and water.
Patent AU-2017203998-A1 (AU)
Title: H2O-based electrochemical hydrogen-catalyst power system
Inventor: MILLS RANDELL L
IPC: H01M4/96
Filed: 2017-06-14
Abstract: H20-Based Electrochemical Hydrogen-Catalyst Power System Abstract An electrochemical power system is provided that generates an electromotive force (EMF) from the catalytic reaction of hydrogen to lower energy (hydrino) states providing direct conversion of the energy released from the hydrino reaction into electricity, the system comprising at least two components chosen from: H20 catalyst or a source of H20 catalyst; atomic hydrogen or a source of atomic hydrogen; reactants to form the H20 catalyst or source of H2 0 catalyst and atomic hydrogen or source of atomic hydrogen; and one or more reactants to initiate the catalysis of atomic hydrogen. The electrochemical power system for forming hydrinos and electricity can further comprise a cathode compartment comprising a cathode, an anode compartment comprising an anode, optionally a salt bridge, reactants that constitute hydrino reactants during cell operation with separate electron flow and ion mass transport, and a source of hydrogen. Due to oxidation-reduction cell half reactions, the hydrino-producing reaction mixture is constituted with the migration of electrons through an external circuit and ion mass transport through a separate path such as the electrolyte to complete an electrical circuit. A power source and hydride reactor is further provided that powers a power system comprising (i) a reaction cell for the catalysis of atomic hydrogen to form hydrinos, (ii) a chemical fuel mixture comprising at least two components chosen from: a source of H2 0 catalyst or H2 0 catalyst; a source of atomic hydrogen or atomic hydrogen; reactants to form the source of H20 catalyst or H20 catalyst and a source of atomic hydrogen or atomic hydrogen; one or more reactants to initiate the catalysis of atomic hydrogen; and a support to enable the catalysis, (iii) thermal systems for reversing an exchange reaction to thermally regenerate the fuel from the reaction products, (iv) a heat sink that accepts the heat from the power-producing reactions, and (v) a power conversion system.
Patent AU-2017206168-A1 (AU)
Title: A Line Strainer
Inventor: WADE ROBERT ANDREW
IPC: F16G11/12
Filed: 2017-07-18
Abstract: A line strainer is disclosed, as well as an electric fence system and method of installation. The line strainer may include a spool having an electrically conductive axle with a first end and a second end. A securing mechanism at the first end of the axle may be configured to secure an electrically conductive link to the spool such that an electrical pathway is provided between the conductive link and the spool at the first end of the axle, the securing mechanism including a bearing member configured to act against the conductive link when secured by the securing mechanism. The bearing member may include at least one elongate recess on a surface of the bearing member facing the first end of the axle, the recess configured to receive at least a portion of the conductive link.
Patent AU-2017208228-A1 (AU)
Title: Annotation of a wavefront
Inventor: BOTZER LIOR
IPC: A61B5/352
Filed: 2017-07-25
Abstract: A method, including receiving a bipolar signal from a pair of electrodes in proximity to a myocardium of a human subject and receiving a unipolar signal from a selected one of the pair of electrodes. The method further includes computing a local unipolar minimum derivative of the unipolar signal, and a time of occurrence of the unipolar minimum derivative. The method also includes computing a bipolar derivative of the bipolar signal, evaluating a ratio of the bipolar derivative to the local unipolar minimum derivative, and when the ratio is greater than a preset threshold ratio value, identifying the time of occurrence as a time of activation of the myocardium. L.Lj CDcl~f D < < D o 0 L.Li - - 0-0 H- C(-) C-)) ~~ -J H-Ca r-)c~ wDL C/) > C)/ 00 C, ( U)m C, C 0LLI LI i wL H- H- H C) C
Patent AU-2017208339-A1 (AU)
Title: Anti-NGF compositions and use thereof
Inventor: DUTZAR BENJAMIN H
IPC: C12N15/13
Filed: 2017-07-28
Abstract: Abstract The present invention is directed to antibodies and fragments thereof having binding specificity for NGF, especially those that inhibit the interaction of NGF with TrkA and/or p75 or p75 and/or TrkA. Another embodiment of this invention relates to the antibodies described herein, and binding fragments thereof, comprising the sequences of the VH, VL and CDR polypeptides described herein, and the polynucleotides encoding them. The invention also contemplates conjugates of anti-NGF antibodies and binding fragments thereof conjugated to one or more functional or detectable moieties. The invention also contemplates methods of making said anti-NGF antibodies and binding fragments thereof. Embodiments of the invention also pertain to the use of anti-NGF antibodies, and binding fragments thereof, for the diagnosis, assessment and treatment of diseases and disorders associated with NGF.
Patent AU-2017221474-A1 (AU)
Title: Systems for processing waste to form useable products and methods thereof
Inventor: MARDIKIAN ALBERT
IPC: F26B20/00
Filed: 2017-02-17
Abstract: The present invention discloses low cost, on-site, efficient, and compact (stationary or mobile) system for continuous (non-batch operation) conversion of waste to usable products such as sources of energy, fertilizer, etc.
Patent AU-2017245471-A1 (AU)
Title: Process for producing liquid hydrocarbon
Inventor: IVERSEN STEEN BRUMMERSTEDT
IPC: C10G1/02
Filed: 2017-10-13
Abstract: The invention relates to a continuous process for converting carbonaceous material contained in one or more feedstocks into a liquid hydrocarbon product, said feedstocks including the carbonaceous material being in a feed mixture including one or more fluids, said fluids including water and further liquid organic compounds at least partly produced by the process in a concentration of at least 1 % by weight, where the process comprises converting at least part of the carbonaceous material by pressurising the feed mixture to a pressure in the range 250-400 bar; heating the feed mixture to a temperature in the range 370-450 'C, and maintaining said pressurized and heated feed mixture in the desired pressure and temperature ranges in a reaction zone for a pre -defined lime; cooling the feed mixture lo a temperature in the range 25-200 'C and expanding the feed mixture to a pressure in the range of 1-70 bar, thereby causing the carbonaceous material to be converted to a liquid hydrocarbon product and separating from the converted feed mixture a fraction comprising liquid hydrocarbon product. WO 2012/167794 PCT/DK2012/000071 Raw material(s) Liquid organic I1. Pretreatment L- Homogeneous) Compound(-s) fcatalyst(-s) a. Pressurization I b. Heating 2. Converting c. Reacting d. Cooling 3. Cooling e. Expanding I expanding hydrocarbon 4. Separation Residual __r fraction fraction Fig. 1
Patent AU-2017265063-A1 (AU)
Title: Emulsified composition and milk drink
Inventor: MATSUURA TSUTASHI
IPC: A23C11/00
Filed: 2017-11-22
Abstract: An emulsified composition comprising a dairy product, an emulsifier, and a magnesium material, wherein the dairy product has a total solid content of 20 mass% or more, and has the ratio of milk fat to total solids of 30 mass% or more, and the mass ratio between fat and magnesium in the emulsified composition (fat : magnesium) is 1 : 0.0003 to 1: 0.01.
Patent AU-2017268348-A1 (AU)
Title: T-cell modulatory multimeric polypeptides and methods of use thereof
Inventor: SEIDEL III RONALD D
IPC: A61K48/00
Filed: 2017-05-17
Abstract: The present disclosure provides T-cell modulatory multimeric polypeptides comprising two different immunomodulatory polypeptides, at least one of which is a variant immunomodulatory polypeptide. The present disclosure provides nucleic acids comprising nucleotide sequences encoding the T-cell modulatory multimeric polypeptides, and host cells comprising the nucleic acids. The present disclosure provides methods of modulating the activity of a T cell; the methods comprise contacting the T cell with a T-cell modulatory multimeric polypeptide of the present disclosure.
Patent AU-2017281083-A1 (AU)
Title: Cysteine engineered fibronectin type iii domain binding molecules
Inventor: ANDERSON MARK
IPC: C07K16/28
Filed: 2017-06-21
Abstract: Cysteine engineered monospecific and bispecific EGFR and/or c-Met FN3 domain containing molecules comprising one or more free cysteine amino acids are prepared by mutagenizing a nucleic acid sequence of a parent molecule and replacing one or more amino acid residues by cysteine to encode the cysteine engineered FN3 domain containing monospecific or bispecific molecules; expressing the cysteine engineered FN3 domain containing molecules; and recovering the cysteine engineered FN3 domain containing molecule, isolated cysteine engineered monospecific or bispecific FN3 domain containing molecules may be covalently attached to a detection label or a drug moiety and used therapeutically.
Patent AU-2017291058-A1 (AU)
Title: Trapping mass consisting of an active phase in crystalline form
Inventor: HUGON ANTOINE
IPC: B01J20/02
Filed: 2017-05-17
Abstract: A trapping mass for trapping heavy metals, in particular mercury, contained in a gas or liquid feedstock, said mass comprising: - an active phase in the form of a crystalline phase, said active phase comprising at least one metal sulfide made from a metal M chosen from the group consisting of copper (Cu), chromium (Cr), manganese (Mn), iron (Fe), cobalt (Co), and nickel (Ni); - an amorphous support comprising a material made from aluminium.
Patent AU-2017297107-A1 (AU)
Title: Cleaner
Inventor: JANG JAEWON
IPC: A47L11/40
Filed: 2017-07-14
Abstract: A cleaner according to the present invention comprises: a body forming the external appearance of the cleaner; and a spin mop cleaning module, which supports the body and comprises at least one spin mop disposed to be in contact with a floor while spinning in a clockwise or counterclockwise direction in view from the above of the cleaner. The at least one spin mop has a lower surface disposed to have a changeable inclination angle with regard to the horizontal surface.
Patent AU-2017306233-A1 (AU)
Title: Garment processing device
Inventor: KWAK BYEONGHEON
IPC: D06F37/04
Filed: 2017-05-22
Abstract: The present invention relates to a garment processing device comprising: a drum having a hook portion, the outer peripheral surface of which is incised such that the same is bent inward when an external force is applied thereto; and a ball balancer having a hook containing portion formed to protrude from the outer peripheral surface thereof so as to contain the hook portion, wherein the hook portion is bent and forced against the hook containing portion, and the forward/backward movement of the ball balancer is limited by rotation of the drum.
Patent AU-2017308733-A1 (AU)
Title: Access control for message channels in a messaging system
Inventor: WALKIN LEV
IPC: H04L47/722
Filed: 2017-08-04
Abstract: Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for receiving one or more subscription requests, wherein each subscription request is received from a respective subscriber client and is for a respective channel, authorizing one or more of the subscription requests, wherein each authorized subscription request permits the subscriber client of the request to receive messages published to the channel of the request, receiving one or more messages for publication, wherein each message is received from a respective publisher client and is for publication on a respective channel, for each of the messages, placing the message in a respective buffer for the channel of the message, wherein the messages are present in the buffer during a finite time-to-live period for the buffer, and for one or more of the buffers, sending any messages in the buffer to subscriber clients that are authorized.
Patent AU-2017325971-A1 (AU)
Title: Combination therapy with liposomal antisense oligonucleotides
Inventor: ASHIZAWA ANA TARI
IPC: A61P35/02
Filed: 2017-09-15
Abstract: Provided herein are methods of treating a cancer in a patient comprising administration of an effective amount of a nuclease-resistant polynucleotide that hybridizes to the translation initiation site of a Grb2 nucleic acid in the patient and either a Bcr-Abl tyrosine kinase inhibitor (
Patent AU-2017343976-A1 (AU)
Title: Limitation of noise on light detectors using an aperture
Inventor: DROZ PIERRE-YVES
IPC: G01S7/481
Filed: 2017-10-04
Abstract: The present disclosure relates to limitation of noise on light detectors using an aperture. One example embodiment includes a system. The system includes a lens disposed relative to a scene and configured to focus light from the scene onto a focal plane. The system also includes an aperture defined within an opaque material disposed at the focal plane of the lens. The aperture has a cross-sectional area. In addition, the system includes an array of light detectors disposed on a side of the focal plane opposite the lens and configured to intercept and detect diverging light focused by the lens and transmitted through the aperture. A cross- sectional area of the array of light detectors that intercepts the diverging light is greater than the cross-sectional area of the aperture.
Patent AU-2017345741-A1 (AU)
Title: Motor drive system and method
Inventor: CONEY JASON L
IPC: F04B49/06
Filed: 2017-10-20
Abstract: A water pumping system, a motor drive, and a method of starting pumping by the motor drive. The method includes performing repeated starting attempts to overcome stiction in a progressive cavity pump by attempting to supply power to an electrical motor at increasing power levels in each starting attempt and supplying the power at the increasing power levels if the power is available from a power source; and after each starting attempt: reducing the power applied to the electrical motor to a reduced power level; determining a rotational speed of the electrical motor; determining if the rotational speed matches a speed corresponding to the reduced power level applied to the electrical motor; if the rotational speed does not match and a predetermined number of starting attempts has not been reached, performing a next starting attempt; and if the rotational speed does match, entering a normal mode of operation.
Patent AU-2017360093-A1 (AU)
Title: Bispecific polypeptides to GITR and CTLA-4
Inventor: ELLMARK PETER
IPC: C07K14/705
Filed: 2017-11-21
Abstract: The present invention provides multispecific polypeptides, such as bispecific antibodies, comprising a first binding domain capable of specifically binding to GITR, and a second binding domain capable of specifically binding to CTLA-4. The invention further provides compositions of said bispecific polypeptides, as well as methods and uses of the same.
Patent AU-2017364747-A1 (AU)
Title: Anode slurry for secondary battery
Inventor: HO KAM PIU
IPC: H01M4/36
Filed: 2017-11-17
Abstract: Provided herein is an anode slurry for lithium-ion batteries, comprising a silicon-based material, a porous carbon aerogel, a binder material, a carbon active material, and a solvent, wherein the porous carbon aerogel has an average pore size from about 80 nm to about 500 nm. The porous carbon aerogel in the anode slurry disclosed herein provides sufficient space for expansion of the silicon-based material during intercalation of lithium ions. Cracking of the silicon-containing anode layer is prevented.
Patent AU-2017377139-A1 (AU)
Title: Probiotics for use in the treatment of diverticulosis and diverticular disease
Inventor: BIFFI ANDREA
IPC: A61K9/14
Filed: 2017-12-15
Abstract: The present invention relates to the use of probiotics to control the inflammatory process of the colon in subjects with structural modifications of the colon wall, preferably in subjects with diverticulosis, and affected by diverticular disease.
Patent AU-2017386122-A1 (AU)
Title: Rigid and flexible laparoscopic multiple component material dispensing devices and methods
Inventor: SPIVEY JAMES T
IPC: A61B17/00
Filed: 2017-11-29
Abstract: A dispensing device to deliver a multiple component material to a location
Patent AU-2018200541-A1 (AU)
Title: Antibodies to olanzapine and use thereof
Inventor: HRYHORENKO ERIC
IPC: G01N33/53
Filed: 2018-01-23
Abstract: Abstract Disclosed is an antibody which binds to olanzapine, which can be used to detect olanzapine in a sample such as in a competitive immunoassay method. The antibody can be used in a lateral flow assay device for point-of-care detection of olanzapine, including multiplex detection of aripiprazole, olanzapine, quetiapine, and risperidone in a single lateral flow assay device.
Patent AU-2018201487-A1 (AU)
Title: Method and system for health monitoring and fault signature identification
Inventor: MALHOTRA PANKAJ
IPC: G06F11/32
Filed: 2018-03-01
Abstract: METHOD AND SYSTEM FOR HEALTH MONITORING AND FAULT SIGNATURE IDENTIFICATION System and method for health monitoring and fault signature identification of a system are disclosed. In an embodiment, the system, estimates Health Index (HI) of the system as time series data. By analyzing data corresponding to the estimated HI, the system identifies one or more time windows in which majority of the estimated HI values are low as a low HI window, and one or more time windows in which majority of the estimated HI values are high as a high HI window. Upon identifying a low HI window, which indicates an abnormal behavior of the system being monitored, the system, based on a local Bayesian Network generated for the system being monitored, generates an Explainability Index (EI) for each sensor, wherein the El quantifies contribution of the sensor to the low HI. Further, associated component(s) is identified as contributing to the abnormal/faulty behavior of the system. Estimating Health Index (HI) of the system as a time series data Identifying a low HI as an abnormal behavior of the system Abnormal behavior No detected? Yes Detecting system component(s) responsible for the abnormal behavior, based on the HI values and sensor readings Fig. 2
Patent AU-2018202343-A1 (AU)
Title: Operating light emitting diodes at low temperature
Inventor: JOHNSTON SCOTT D
IPC: G05F1/00
Filed: 2018-04-03
Abstract: Light-emitting diodes (LEDs) generate light more efficiently than high-intensity discharge lamps or high-intensity fluorescent lamps. Driving a series of LEDs with a constant-voltage primary supply and a low-voltage LED driver keeps efficiency high. Unfortunately, LED forward voltage varies as a function of temperature: at low temperature, the forward voltage rises. Placing the LEDs in series magnifies the forward voltage increases. This makes it difficult to drive a series of LEDs at low temperature with a constant-voltage supply because the forward voltage can exceed the power supply voltage. To account for this behavior, an exemplary LED lighting fixture includes a "bypass" circuit that, when engaged, effectively removes at least one LED from each series string of LEDs to bring the total forward voltage below the power supply voltage. The low-voltage driver circuit monitors temperature, and engages the "bypass" circuit when necessary to ensure that DC voltage is not exceeded. See Fig. 3A. WO 2014/179379 PCT/US201-4/035990 C:, C/) aD (0 C)CI
Patent AU-2018203653-A1 (AU)
Title: Novel fusion molecules and uses thereof
Inventor: LIPSON DORON
IPC: C07K14/71
Filed: 2018-05-23
Abstract: Novel fusion molecules and uses are disclosed.
Patent AU-2018213716-A1 (AU)
Title: Prophylactic and/or therapeutic agent of infectious disease or inflammatory disease
Inventor: SUZUKI KAZUO
IPC: C12N15/09
Filed: 2018-01-26
Abstract: [Problem] To provide a therapeutic method dedicated to infectious diseases or inflammatory diseases such as intractable vasculitis, said method being different than therapeutic methods of the prior art in which target molecules are not specified, by specifying target molecules that are effective for treating the abovementioned diseases. [Solution] According to one embodiment of the present invention, a preventive and/or therapeutic agent for infectious diseases or inflammatory diseases is provided, said agent containing, as an active ingredient, antibodies that specifically recognize apolipoprotein A2 (APOA2).
Patent AU-2018231413-A1 (AU)
Title: Treatment of pruritus in horses
Inventor: FETTELSCHOSS ANTONIA
IPC: C07K14/54
Filed: 2018-03-07
Abstract: The present invention relates to compositions, immunogenic or vaccine compositions and pharmaceutical compositions for the prevention or treatment of a condition or disorder selected from a pruritic condition or an allergic condition, of equine mammals, preferably of horses. Furthermore, the invention provides methods for preventing or treating pruritus, preferably pruritus associated with a pruritic condition or an allergic condition such as allergic dermatitis, of equine mammals, preferably of horses.
Patent AU-2018234135-A1 (AU)
Title: Terminal apparatus, core network apparatus, and communication control method
Inventor: KAWASAKI Yudai
IPC: H04W24/02
Filed: 2018-03-14
Abstract: Provided is a communication means for registering information about a terminal device in various devices, such as a control device and a terminal device, included in a communication system in which a protocol used for registration management or registration information management for a mobile communication service is standardized, on the basis of the states of the various devices. Also provided is a communication control means for updating the information about the terminal device registered in the various devices. Thus, there are provided, in a communication system in which a protocol used for registration management or registration information management for a mobile communication service is standardized, a means for registration management based on the state of various devices included in the communication system, such as a control device and a terminal device, and a realization means for determining post-registration behavior.